Shujun J. Yang
No 1 Eastern Jianshe Road
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Safety of fruquintinib mono- and combo therapy in metastatic colorectal cancer: real-world subgroup analysis from China.
Journal: Future oncology (London, England)
Published: May 28, 2026
Safety of fruquintinib in Chinese patients with colorectal cancer: an age subgroup analysis from a phase IV real-world clinical practice study.
Journal: Therapeutic advances in medical oncology
Published: March 10, 2025
A B7H3-targeting antibody-drug conjugate in advanced solid tumors: a phase 1/1b trial.
Journal: Nature medicine
Published: October 08, 2024
Efficacy and safety of regorafenib as second-line treatment for patients with hepatocellular carcinoma and macrovascular invasion and(or) extrahepatic metastasis.
Journal: Journal of gastrointestinal oncology
Published: August 05, 2023
KN046, a bispecific antibody against PD-L1 and CTLA-4, plus chemotherapy as first-line treatment for metastatic NSCLC: A multicenter phase 2 trial.
Journal: Cell reports. Medicine
Published: July 21, 2023
Real-world effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer: A retrospective, observational study.
Journal: Asia-Pacific journal of clinical oncology
Published: April 25, 2022
Paclitaxel and cisplatin with or without cetuximab in metastatic esophageal squamous cell carcinoma: a randomized, multicenter phase II trial.
Journal: Innovation (Cambridge (Mass.))
Published: December 14, 2021
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.
Journal: Cancer cell
Published: November 02, 2021
Last Updated: 09/26/2026